Showing results (81-90 of 759) with videos related to
Sort By:
Pageof 76
Expert Review of Precision Medicine and Drug Development|August 20, 2021
Proteomics-inspired precision medicine for treating and understanding multiple myelomaMatthew Ho, Giada Bianchi, Kenneth C AndersonLeukemia & Lymphoma|August 28, 2010
Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patientsMeghan Rourke, Kenneth C Anderson, Irene M GhobrialJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Best treatment strategies in high-risk multiple myeloma: navigating a gray areaGiada Bianchi, Paul G Richardson, Kenneth C AndersonImmunotargets and Therapy|October 29, 2020
Immunotherapeutic and Targeted Approaches in Multiple MyelomaOmar Nadeem, Yu-Tzu Tai, Kenneth C AndersonExpert Opinion on Investigational Drugs|January 26, 2006
Current therapeutic uses of lenalidomide in multiple myelomaTeru Hideshima, Paul G Richardson, Kenneth C AndersonMolecular Cancer Therapeutics|November 11, 2011
Mechanism of action of proteasome inhibitors and deacetylase inhibitors and the biological basis of synergy in multiple myelomaTeru Hideshima, Paul G Richardson, Kenneth C AndersonCancer Control : Journal of the Moffitt Cancer Center|October 29, 2003
Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancersPaul G Richardson, Teru Hideshima, Kenneth C AndersonReviews in Clinical and Experimental Hematology|February 7, 2004
Targeting proteasome inhibition in hematologic malignanciesTeru Hideshima, Paul G Richardson, Kenneth C AndersonHematology/Oncology Clinics of North America|September 13, 2014
Immunotherapy strategies in multiple myelomaJooeun Bae, Nikhil C Munshi, Kenneth C AndersonThescientificworldjournal|December 13, 2006
New frontiers in the treatment of multiple myelomaJanice Jin Hwang, Irene M Ghobrial, Kenneth C AndersonPageof 76